ELYM - Eliem Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Eliem Therapeutics's activity chart (see below) currently has 8 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 361.43 days.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 08-Mar-2023. First documented stock forecast 07-Sep-2021.

Best performing analysts who are covering ELYM - Eliem Therapeutics:

Douglas Tsao Marc Goodman Paul Matteis Yatin Suneja

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Mar-2023

$6

$2.91 (94.17%)

3 years 7 months 24 days ago
(08-Mar-2023)

2/2 (100%)

$2.36 (64.84%)

485

Buy Since 07-Sep-2021

$4

$0.91 (29.45%)

4 years 2 months 16 days ago
(16-Aug-2022)

1/2 (50%)

$1.11 (38.41%)

141

Buy Since 07-Sep-2021

$8

$4.91 (158.90%)

4 years 2 months 30 days ago
(02-Aug-2022)

1/4 (25%)

$5.28 (194.12%)

639

Hold Since 26-Apr-2022

$32

4 years 6 months 6 days ago
(26-Apr-2022)

0/1 (0%)

$3.39 (11.85%)

Show more analysts

Please expand the browser size to see the chart

What is ELYM (Eliem Therapeutics) average time for price targets to be met?

On average it took 361 days for the stock forecasts to be reached, with an average price target met ratio of 50%.

Which analyst most recently updated their price target on ELYM (Eliem Therapeutics)?

Douglas Tsao

Which analyst has the most public recommendations on ELYM (Eliem Therapeutics)?

Douglas Tsao has 7 price targets and 7 ratings on ELYM

Which analyst is the currently most bullish on ELYM (Eliem Therapeutics)?

Paul Matteis with the highest potential upside of $4.91

Which analyst is the currently most reserved on ELYM (Eliem Therapeutics)?

Yatin Suneja with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?